BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gupta T, Jarpula NS. Hepatocellular carcinoma immune microenvironment and check point inhibitors-current status. World J Hepatol 2024; 16(3): 353-365 [PMID: 38577535 DOI: 10.4254/wjh.v16.i3.353]
URL: https://www.wjgnet.com/1948-5182/full/v16/i3/353.htm
Number Citing Articles
1
Xiao-Wei Wang, Yu-Xing Tang, Fu-Xi Li, Jia-Le Wang, Gao-Peng Yao, Da-Tong Zeng, Yu-Lu Tang, Bang-Teng Chi, Qin-Yan Su, Lin-Qing Huang, Di-Yuan Qin, Gang Chen, Zhen-Bo Feng, Rong-Quan He. Clinical significance of upregulated Rho GTPase activating protein 12 causing resistance to tyrosine kinase inhibitors in hepatocellular carcinomaWorld Journal of Gastrointestinal Oncology 2024; 16(10): 4244-4263 doi: 10.4251/wjgo.v16.i10.4244